European Respiratory Review

Article	Citations
Reply to: “Nicotine or tobacco abstinence?”	261
European Respiratory Review, list of peer reviewers 2022	197
Ventilation/perfusion mismatch is not the sole reason for hypoxaemia in early stage COVID-19 patients	181
Health disparities and associated social determinants of health in interstitial lung disease: a narrative review	129
Cough monitoring systems in adults with chronic respiratory diseases: a systematic review	126
European Respiratory Review, list of peer reviewers 2023	124
Smouldering fire or conflagration? An illustrated update on the concept of inflammation in pulmonary arterial hypertension	113
Liposomal drug delivery to manage nontuberculous mycobacterial pulmonary disease and other chronic lung infections	107
Exacerbations of bronchiectasis	105
The role of telemonitoring in patients on home mechanical ventilation	90
Lost in translation: a neglected mTOR target for lymphangioleiomyomatosis	89
ERS/EAACI statement on adherence to international adult asthma guidelines	86
Association of preserved ratio impaired spirometry with mortality: a systematic review and meta-analysis	80
Live teleultrasound for evaluation of the chest: a systematic review	79
Treatable traits in asthma during pregnancy: a call for a shift towards a precision-based management approach	78
Advance care planning in patients with respiratory failure	77
Lung stem cells and respiratory epithelial chimerism in transplantation	76
Toll-like receptor-agonist-based therapies for respiratory viral diseases: thinking outside the cell	70
Global respiratory health priorities at the beginning of the 21st century	69
Inhaled corticosteroids for the treatment of COVID-19	66
Quality of life in patients with chronic respiratory failure on home mechanical ventilation	66
The re-emerging role of linoleic acid in paediatric asthma	62
Epidemiology of severe asthma in children: a systematic review and meta-analysis	62
Air pollution as an early determinant of COPD	61
Multiple breath washout and oscillometry after allogenic HSCT: a scoping review	61

WASOG statement on the diagnosis and management of sarcoidosis-associated pulmonary hypertension	60
Diaphragm excursion and diaphragm thickening fraction: commonality and conflict	57
Characteristics of scores used for quantitative lung ultrasound in neonates: a systematic review	56
Sarcopenia in interstitial lung disease	56
Contemporary issues in the implementation of lung cancer screening	55
Mucolytics for acute exacerbations of chronic obstructive pulmonary disease: a meta-analysis	54
Integrating asthma care guidelines into primary care electronic medical records: a review focused on Canadian knowledge translation tools	53
Sex and gender in interstitial lung diseases	53
Phenotype overlap in the natural history of asthma	50
The ageing of people living with cystic fibrosis: what to expect now?	50
Smoking cessation and vaccination	50
Methods to assess COPD medications adherence in healthcare databases: a systematic review	49
Pathophysiology and genomics of bronchiectasis	49
A pulmonologist's guide to perform and analyse cross-species single lung cell transcriptomics	48
Sensitivity and complications of thoracentesis and thoracoscopy: a meta-analysis	47
Nonpharmacological interventions in COPD	45
Diagnostic yield and safety of diagnostic techniques for pulmonary lesions: systematic review, meta-analysis and network meta-analysis	44
Sex and gender in respiratory physiology	44
Recreating chronic respiratory infectionsin vitrousing physiologically relevant models	43
Balancing the value and risk of exercise-based therapy post-COVID-19: a narrative review	42
REM sleep obstructive sleep apnoea	41
Airway ciliated cells in adult lung homeostasis and COPD	41
Measuring pulmonary function in COPD using quantitative chest computed tomography analysis	41
Mitogen-activated protein kinase-guided drug discovery for post-viral and related types of lung disease	40
Pro: Clinical remission in asthma – implications for asthma management	40
Advanced imaging techniques and artificial intelligence in pleural diseases: a narrative review	40
Extreme weather and asthma: a systematic review and meta-analysis	39
Clinical utility of WHO-recommended screening tools and development and validation of novel clinical prediction models for pulmonary tuberculosis screening among outpatients living with HIV: an indivi	38
Sex and gender in pulmonary arterial hypertension	38
Investigating the prognostic value of digital mobility outcomes in patients with chronic obstructive pulmonary disease: a systematic literature review and meta-analysis	38
Clinical significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in acute exacerbations of COPD: present and future	37
Recovering from a pandemic: pulmonary fibrosis after SARS-CoV-2 infection	36
Antibiotic resistance in chronic respiratory diseases: from susceptibility testing to the resistome	36
Interplay between respiratory viruses and cilia in the airways	35
Sex and gender in lung health and disease: more than just Xs and Ys	35
Pathogenesis-driven treatment of primary pulmonary alveolar proteinosis	35
Adherence-enhancing interventions for pharmacological and oxygen therapy in patients with COPD: a systematic review and component network meta-analyses	35
Bronchiolar disorders in systemic autoimmune rheumatic diseases	34
The oesophageal balloon for respiratory monitoring in ventilated patients: updated clinical review and practical aspects	34
Extrapulmonary effects of lung volume reduction in severe emphysema: a systematic review	34
COVID-19 and tuberculosis: the double whammy of respiratory pathogens	34
Diagnostic yield and safety of transbronchial lung cryobiopsy and surgical lung biopsy in interstitial lung diseases: a systematic review and meta-analysis	33
Systematic review on long-term adverse effects of inhaled corticosteroids in the treatment of COPD	32
The persistent inflammation in COPD: is autoimmunity the core mechanism?	32
Rare thoracic cancers: a comprehensive overview of diagnosis and management of small cell lung cancer, malignant pleural mesothelioma and thymic epithelial tumours	32
Subclinical tuberculosis: a meta-analysis of prevalence and scoping review of definitions, prevalence and clinical characteristics	32
“Exercise intolerance in pulmonary arterial hypertension: insight into central and peripheral pathophysiological mechanisms.” S. Malenfant, M. Lebret, É. Breton-Gagnon,et al.Eur Respir Rev	31
Positive airway pressure therapy for post-stroke sleep disordered breathing: a systematic review, meta-analysis and meta-regression	31
Preclinical models of maternal asthma and progeny outcomes: a scoping review	31
Does pulmonary rehabilitation address treatable traits? A systematic review	30

The epithelial era of asthma research: knowledge gaps and future direction for patient care	29
Parasitic lung diseases	29
Medication adherence to CFTR modulators in patients with cystic fibrosis: a systematic review	29
Prevalence, imaging patterns and risk factors of interstitial lung disease in connective tissue disease: a systematic review and meta-analysis	29
Natural killer cells in the lung: potential role in asthma and virus-induced exacerbation?	29
Targeting interleukin-33 and thymic stromal lymphopoietin pathways for novel pulmonary therapeutics in asthma and COPD	28
New trends in pulmonary hypertension	28
Molecular monitoring of lung allograft health: is it ready for routine clinical use?	28
Polyphenols, flavonoids and inflammasomes: the role of cigarette smoke in COPD	28
Phage therapy for pulmonary infections: lessons from clinical experiences and key considerations	28
Association between second-hand smoke exposure and lung cancer risk in never-smokers: a systematic review and meta-analysis	28
Evidence-based management of symptoms in serious respiratory illness: what is in our toolbox?	27
Breathing techniques to reduce symptoms in people with serious respiratory illness: a systematic review	27
Fixed-intensity exercise tests to measure exertional dyspnoea in chronic heart and lung populations: a systematic review	27
From treatable traits to GETomics in airway disease: moving towards clinical practice	27
Impact of ageing and pregnancy on the minute ventilation/carbon dioxide production response to exercise	26
E-cigarettes and nicotine abstinence: a meta-analysis of randomised controlled trials	25
A scoping review on the risk of tuberculosis in specific population groups: can we expand the World Health Organization recommendations?	25
Impact of climate change on paediatric respiratory health: pollutants and aeroallergens	25
The association between alcohol consumption and pulmonary function: a scoping review	25
Nitrogen single and multiple breath washout test and lung imaging to detect treatment-related pulmonary toxicity in paediatric cancer patients and survivors: a systematic review	24
Lung cancer occurrence after an episode of tuberculosis: a systematic review and meta-analysis	24
Bronchiectasis in Asia: a review of current status and challenges	24
Antineutrophil cytoplasmic antibody-associated interstitial lung disease: a review	24
Recycling plastic: diagnosis and management of plastic bronchitis among adults	24
Predictors of sleep disordered breathing in children with Down syndrome: a systematic review and meta-analysis	24
“Targeting interleukin-33 and thymic stromal lymphopoietin pathways for novel pulmonary therapeutics in asthma and COPD”. Ariel A. Calderon, Colin Dimond, David F. Choy, Rajita Pappu, Michele A. Grimb	23
Digital twins for chronic lung diseases	23
Hypoxaemia in the early stage of COVID-19: prevalence of physical or biochemical factors?	23
Managing an ageing cystic fibrosis population: challenges and priorities	22
Biologics in severe asthma: the role of real-world evidence from registries	22
Global birth prevalence of Robin sequence in live-born infants: a systematic review and meta-analysis	22
Supplemental oxygen for symptomatic relief in people with serious respiratory illness: a systematic review and meta-analysis	22
Physical activity measurements in individuals with interstitial lung disease: a systematic review and meta-analysis	22
Stem cell therapy in pulmonary hypertension: current practice and future opportunities	21
Clinical utility of diagnostic biomarkers in malignant pleural mesothelioma: a systematic review and meta-analysis	21
The role of antibodies in tuberculosis diagnosis, prophylaxis and therapy: a review from the ESGMYC study group	21
Risk of serious COVID-19 outcomes among adults and children with moderate-to-severe asthma: a systematic review and meta-analysis	20
Prognostic value of echocardiography-derived right ventricular dysfunction in haemodynamically stable pulmonary embolism: a systematic review and meta-analysis	20
Cytokine-targeted therapies for asthma and COPD	20
Protected characteristics reported in pulmonary rehabilitation: a scoping review	20
Lack of diversity in antifibrotic trials for pulmonary fibrosis: a systematic review	20
The guardians of pulmonary harmony: alveolar macrophages orchestrating the symphony of lung inflammation and tissue homeostasis	20
Gait differences between COPD and healthy controls: systematic review and meta-analysis	20
Antibody-mediated protection against respiratory syncytial virus in children	20
Neutrophil dynamics in pulmonary fibrosis: pathophysiological and therapeutic perspectives	20
Lung transplantation for COPD/pulmonary emphysema	20
Inhaledversussystemic corticosteroids for acute exacerbations of COPD: a systematic review and meta-analysis	20
Sex and gender in asthma	19
Diaphragmatic palsy following lung transplantation	19
Clinimetric properties of field exercise tests in cystic fibrosis: a systematic review	19
Nebulised granulocyte–macrophage colony-stimulating factor (GM-CSF) in autoimmune pulmonary alveolar proteinosis: a systematic review and meta-analysis	19
Determining the minimum important differences for field walking tests in adults with long–term conditions: a systematic review and meta-analysis	19
Risk factors for asthma exacerbations during pregnancy: a systematic review and meta-analysis	19
A narrative review of chemokine receptors CXCR1 and CXCR2 and their role in acute respiratory distress syndrome	18
Reporting of pre-existing multiple long-term conditions in physical rehabilitation for long COVID: a scoping review	18
“Strength of association between comorbidities and asthma: a meta-analysis” Paola Rogliani, Rossella Laitano, Josuel Ora, Richard Beasley and Luigino Calzetta.Eur Respir Rev2023; 32: 220202	18
The 6-min walk test as a primary end-point in interstitial lung disease	18
The effect of graded exercise therapy on fatigue in people with serious respiratory illness: a systematic review	18
Ventilation in the obese: physiological insights and management	17
Biomarkers in lower respiratory tract samples in the diagnosis of ventilator-associated pneumonia: a systematic review	17
Lysophosphatidic acid receptor 1 inhibition: a potential treatment target for pulmonary fibrosis	17
Mediastinal tumours and pseudo-tumours: a comprehensive review with emphasis on multidisciplinary approach	17
In vivodetection of pulmonary mucociliary clearance: present challenges and future directions	17
Role of air pollutants in airway epithelial barrier dysfunction in asthma and COPD	16
Forbearance with endobronchial stenting: cognisance before conviction	16
Pulmonary rehabilitation and physical interventions	16
Biochemical shunt: where and how?	16
How inhaled corticosteroids target inflammation in COPD	16
Update on recent key publications in lung oncology: picking up speed	16
Unravelling the mechanisms driving multimorbidity in COPD to develop holistic approaches to patient-centred care	15
The evolution ofin vitromodels of lung fibrosis: promising prospects for drug discovery	15
The flare of care for rare: per aspera ad astra for rare lung diseases!	15
Multicomponent services for symptoms in serious respiratory illness: a systematic review and meta-analysis	15
End-point definition and trial design to advance tuberculosis vaccine development	15
Performance-based outcome measures to assess functionality in hospitalised patients with COPD exacerbations: a systematic review of the measurement properties	15
Guidance and standard operating procedures for functional exercise testing in cystic fibrosis	15
CDK4/6 inhibitors in lung cancer: current practice and future directions	15
Phosphodiesterase 4B inhibition: a potential novel strategy for treating pulmonary fibrosis	14
Understanding the pathogenesis of occupational coal and silica dust-associated lung disease	14

“Noninvasive respiratory support after extubation: a systematic review and network meta-analysis”. A. Boscolo, T. Pettenuzzo, N. Sella, M. Zatta, M. Salvagno, M. Tassone, C. Pretto, A. Peralta, L. Mur	14
Opioids for the palliation of symptoms in people with serious respiratory illness: a systematic review and meta-analysis	14
Predicting the pulmonary effects of long-term e-cigarette use: are the clouds clearing?	14
No smoke without fire: the impact of cigarette smoking on the immune control of tuberculosis	13
“How will lung cancer screening and lung nodule management change the diagnostic and surgical lung cancer landscape?”. G. Hardavella, A. Frille, R. Chalela, K.B. Sreter, R.H. Petersen, N. Novoa and H.	13
Airway epithelium in lung transplantation: a potential actor for post-transplant complications?	13
State-of-the-art review of lung imaging in cystic fibrosis with recommendations for pulmonologists and radiologists from the “iMAging managEment of cySTic fibROsis” (MAESTRO) consortium	13
Clinical–radiological–pathological correlation in pulmonary hypertension with unclear and/or multifactorial mechanisms	13
Update on molecular pathology and role of liquid biopsy in nonsmall cell lung cancer	13
The role of vascularity and the fibrovascular interface in interstitial lung diseases	13
Pulmonary veno-occlusive disease: illustrative cases and literature review	12
Platelets: a potential role in chronic respiratory diseases?	12
Sex, gender and the pulmonary physiology of exercise	12
Patient-reported outcomes to assess dyspnoea in interstitial lung disease and pulmonary hypertension: a systematic literature review of measurement properties	12
“Immune mechanisms in fibrotic pulmonary sarcoidosis”. P. Weeratunga, D.R. Moller and L-P. Ho.Eur Respir Rev2022; 31: 220178	12
The impact of therapeutics on mortality in hospitalised patients with COVID-19: systematic review and meta-analyses informing the European Respiratory Society living guideline	12
EMBARCing on a new era for bronchiectasis: a review series for the Seventh World Bronchiectasis Conference	12
Phage therapy: breathing new tactics into lower respiratory tract infection treatments	12
Montelukast in paediatric asthma and allergic rhinitis: a systematic review and meta-analysis	11
The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review	11
Disease burden associated with alpha-1 antitrypsin deficiency: systematic and structured literature reviews	11
Lung volumes, gas transfer and oscillometry after preterm birth: systematic review and meta-analysis	11
Managing respiratory muscle weakness during weaning from invasive ventilation	11
Cryptogenic organising pneumonia: current understanding of an enigmatic lung disease	11
Fine particulate matter manipulates immune response to exacerbate microbial pathogenesis in the respiratory tract	11
Physical activity promotion interventions in chronic airways disease: a systematic review and meta-analysis	11
Transient tachypnoea: new concepts on the commonest neonatal respiratory disorder	11
Particulate matter-induced epigenetic modifications and lung complications	11
Treating central sleep apnoea in heart failure: is positive airway pressure and adaptive servo-ventilation in particular the gold standard?	11
A systematic review of procedural and sampling techniques for cryobiopsy in interstitial lung disease	11
Respiratory management of acute chest syndrome in children with sickle cell disease	10
Nocturnal oxygen therapy in obstructive sleep apnoea: a systematic review and meta-analysis	10
Nine controversial questions about augmentation therapy for alpha-1 antitrypsin deficiency: a viewpoint	10
Severe COVID-19versusmultisystem inflammatory syndrome: comparing two critical outcomes of SARS-CoV-2 infection	10
Strength of association between comorbidities and asthma: a meta-analysis	10
Unsupervised home spirometryversussupervised clinic spirometry for respiratory disease: a systematic methodology review and meta-analysis	10
Neutrophil serine proteases in cystic fibrosis: role in disease pathogenesis and rationale as a therapeutic target	10
Airborne indoor allergen serine proteases and their contribution to sensitisation and activation of innate immunity in allergic airway disease	10
Exploring the translational landscape of the long noncoding RNA transcriptome in acute respiratory distress syndrome: it is a long way to the top	10
A role for club cells in smoking-associated lung adenocarcinoma	9
Respiratory muscle dysfunction in acute and chronic respiratory failure: how to diagnose and how to treat?	9
Thank you from the Chief Editor (2022–2024)	9
Assessing adherence to inhaled therapies in asthma and the emergence of electronic monitoring devices	9
Pulmonary aspergillosis: diagnosis and treatment	9
Pulmonary capillary recruitment and distention in mammalian lungs: species similarities	9
Neutrophilic inflammation in bronchiectasis	9
Ventilatory efficiency in athletes, asthma and obesity	9
Air pollution, metabolites and respiratory health across the life-course	9
“Design of pulmonary rehabilitation programmes during acute exacerbations of COPD: a systematic review and network meta-analysis.” Ana Machado, Pedro Matos Silva, Vera Afreixo, Cátia Caneiras, Chris B	9
Medication adherence, related factors and outcomes among patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension: a systematic review	9
Extracorporeal carbon dioxide removal in acute hypoxaemic respiratory failure: a systematic review, Bayesian meta-analysis and trial sequential analysis	9
Atypical imaging patterns during lung invasive mould diseases: lessons for clinicians	9
European Respiratory Review, list of peer reviewers 2024	8
Animal models of silicosis: fishing for new therapeutic targets and treatments	8
Home mechanical ventilation in children: evolving indications in an era of new treatment options	8
Efficacy and safety of gefapixant for chronic cough: a meta-analysis of randomised controlled trials	8
Noncoding RNAs in asthmatic airway smooth muscle cells	8
The effects of COVID-19 on respiratory muscle performance: making the case for respiratory muscle testing and training	8
The deadly dance of alveolar macrophages and influenza virus	8
Ear and upper airway clinical outcome measures for use in primary ciliary dyskinesia research: a scoping review	8
Con: clinical remission in asthma – not yet there	8
Rare genetic interstitial lung diseases: a pictorial essay	8
Revisiting the role of pulmonary surfactant in chronic inflammatory lung diseases and environmental exposure	8
Exertional ventilation/carbon dioxide output relationship in COPD: from physiological mechanisms to clinical applications	7
The cystic fibrosis lung microenvironment alters antibiotic activity: causes and effects	7
Holy Grail: the journey towards disease modification in asthma	7
Non-typeableHaemophilus influenzaeairways infection: the next treatable trait in asthma?	7
Occupation and SARS-CoV-2 in Europe: a review	7
Correction to subglottic secretion drainage for preventing ventilator-associated pneumonia: an overview of systematic reviews and an updated meta-analysis	7
Obesity, leptin and host defence ofStreptococcus pneumoniae: the case for more human research	7
20 years of neuromuscular electrical stimulation in COPD	7
Multidisciplinary management of tracheobronchial injury	7
The world of rare interstitial lung diseases	7
“Sex and gender differences during the lung lifespan: unveiling a pivotal impact” P. Tondo, C. Meschi, M. Mantero, G. Scioscia, M. Siciliano, M. Bradicich and G.M. Stella, on behalf of the Italian Res	7
Post-COVID-19 dyspnoea and pulmonary imaging: a systematic review and meta-analysis	7
Impairment of hypoxic pulmonary vasoconstriction in acute respiratory distress syndrome	7
Interstitial pneumonia with autoimmune features: challenges and controversies	7
Peripheral blood monocyte count and outcomes in patients with interstitial lung disease: a systematic review and meta-analysis	7